

Associate Professor, Biochemistry & Molecular Biology
Department of Urology, Medical College of Georgia
Jump to: Research FocusPublicationsLab Protocols Collaborations Lab Personnel
The Sharanjot Saini Lab
Health Sciences Campus
GCC - M. Bert Storey Research Building
1410 Laney Walker Blvd., CN-1164
Office |(706) 721-0856
Engineering new paths through treatment-resistant prostate cancer.
I study how aggressive prostate cancers change identity—and how extracellular vesicles can help us detect and target them. My work connects molecular mechanisms with practical therapeutic strategies.
Neuroendocrine prostate cancer can emerge as tumors evade standard therapies. My research follows that transition from molecular drivers to targeted delivery and better disease signals.
Biology that opens new possibilities.

Studying how novel transcription factors drive neuroendocrine differentiation and how mitochondrial resilience and innate immune signaling may expose new vulnerabilities.
Investigating extracellular vesicle and microRNA signals for aggressive disease, alongside the therapeutic potential of plant-derived nanovesicles in prostatic disease.
Selected Works: Peer-reviewed research spanning targeted exosomes, lineage reprogramming, and plant-derived nanovesicles.
Saini S*, Sreekumar A, Nathani S, Asante DM, Simmons MN. A novel exosome based therapeutic intervention against neuroendocrine prostate cancer. Scientific Reports. 2024;14:2816.
Bhagirath D, Yang TL, Tabatabai ZL, Majid S, Dahiya R, Tanaka Y, Saini S*. BRN4 is a novel driver of neuroendocrine differentiation in castration-resistant prostate cancer and is selectively released in extracellular vesicles with BRN2. Clinical Cancer Research. 2019. doi:10.1158/1078-0432.CCR-19-0498.
Bhagirath D, Liston M, Lui B, Yang TL, Olshen A, Tabatabai LZ, Dahiya R, Majid S, Saini S*. A microRNA signature of neuroendocrine differentiation in metastatic castration-resistant prostate cancer. Oncogene. 2020. doi:10.1038/s41388-020-01493-8.
Bhagirath D, Liston M, Akoto T, Lui B, Bensing B, Sharma A, Saini S*. Novel, non-invasive markers for detecting therapy induced neuroendocrine differentiation in castration-resistant prostate cancer patients. Scientific Reports. 2021;11:8279.
Bhagirath D, Yang T, Bucay N, et al., Saini S*. MicroRNA-1246 is an exosomal biomarker for aggressive prostate cancer. Cancer Research. 2018. doi:10.1158/0008-5472.CAN-17-2069.
Sreekumar A, Saini S. Role of transcription factors and chromatin modifiers in driving lineage reprogramming in treatment-induced neuroendocrine prostate cancer. Frontiers in Cell and Developmental Biology. 2023;11:1075707.
Sreekumar A, Simmons MN, Lee TJ, Sharma A, Saini S*. Therapeutic potential of pomegranate juice-derived nanovesicles in benign prostatic hyperplasia xenograft model. Scientific Reports. 2023;13:12427.
Bucay N, Shahryari V, Mitsui Y, et al., Saini S*. MicroRNA-383 located in frequently deleted chromosomal locus 8p22 regulates prostate cancer stem cell marker CD44. Oncogene. 2017;36:2667–2679.
A home for methods and standard operating procedures used across the lab’s research programs.

Extracellular Vesicles
Isolation, characterization, surface engineering, and cargo loading.
Molecular Assays
RNA analysis, gene expression, and protein detection.
Cell & Tissue Models
Cell based assays, imaging, and tissue analysis.
Approved protocol documents will appear here. For a current method, contact the lab.
Interested in neuroendocrine prostate cancer, extracellular vesicles, biomarkers, or translational partnerships? I’d welcome a conversation.
Gifts can be made through Augusta University’s Prostate Cancer Research fund. If you would like your gift directed specifically to research in the Saini lab, please confirm the designation with Philanthropy & Alumni Engagement before donating.

Sharanjot Saini, PhD

Saikiran Battula

Alexis Jones
Former Lab Members

Divya Bhagirath

Thao Ly

Nathan Bucky

Sandeep Nathani

Theresa Akoto

Diana Asante

Amritha Sreekumar

Julie Bishara

Morolake Morakinyo